sglt2 Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 1/2 (1)

Interventional (1)

The University of Texas Health Science Center at San Antonio (1)

Yes (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/haddiabetes

I am/have/hadtype 2 diabetes mellitus

I am/have/hadcognitive assessment

I am/have/hadbody mass index

I am/have/hadoral glucose tolerance test

added new label for I am/have/had

more

I am looking for

I am looking forglycosylated hemoglobin

I am looking forsglt2

I am looking forhba1c

I am looking forblood sugar

I am looking forhemoglobin a1c

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Cardiovascular Diseases
Recruiting

SGLT2 Inhibition in Older Obese Adults With Pre-diabetes

Inhibitors of the sodium-glucose co-transporter (SGLT2) are FDA-approved for the treatment of type 2 diabetes (T2DM). Their mechanism of action involves lowering of blood glucose concentration secondary to increased glucose excretion of glucose by the kidney.

hba1c

blood sugar

glycosylated hemoglobin

sglt2

diabetes

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.